A review on recent advances in drugs for lung cancer treatment

A review on recent advances in drugs for lung cancer treatment

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografske podrobnosti
Glavni avtor:	Noor, Fouzia
Drugi avtorji:	Akter, Raushanara
Format:	Thesis
Jezik:	English
Izdano:	Brac University 2024
Teme:	Lung cancer Recent advances Drugs Resistance Mechanism of action Lung cancer > Treatment
Online dostop:	http://hdl.handle.net/10361/22049

Podobne knjige/članki

Potential of liposomes for the treatment of lung cancer- a review
od: Mim, Shanzida
Izdano: (2023)

A review on targeted therapies for lung cancer
od: Ashraf, Anushey
Izdano: (2023)

Molecules associated with the development of lung cancer
od: Rahman, Adree, et al.
Izdano: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
od: Rahman, Tasnim
Izdano: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
od: Jeba, Joynob
Izdano: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
od: Razna, Amrin Islam
Izdano: (2019)

Immunotherapy in the Management of Lung Cancer
od: Tasnim, Humayra
Izdano: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
od: Pial, Sazia Afrin
Izdano: (2018)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
od: Das, Reshita
Izdano: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Izdano: (2023)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
od: Zangmo, Thinley
Izdano: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
od: Hoque, Ismoth Ara
Izdano: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Flora, Sanzida Alam
Izdano: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
od: Shabnam, Musharrat
Izdano: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
od: Paul, Pulock
Izdano: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
od: Bristy, Israt Zerin
Izdano: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
od: Khondokar, Faiza
Izdano: (2022)

A comprehensive review on drug repurposing in cancer treatment
od: Sarkar, Onusree
Izdano: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
od: Raihan, Dilraj
Izdano: (2024)

Lung cancer detection and classification using machine learning
od: Arefin, Mahbubul, et al.
Izdano: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
od: Nandy, Aditi
Izdano: (2022)

Recent advancement on breast cancer detection and treatment
od: Rahman, Sanjida
Izdano: (2023)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
od: Chakraborty, Anuradha
Izdano: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Izdano: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
od: Nahar, Kamrun
Izdano: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
od: Mukti, Roushney Fatima, et al.
Izdano: (2016)

Identification of the multi-drug resistant genes in the bacteria isolated from the saliva of smoker oral cancer patients and comparative analysis with smoker normal individuals
od: Hasan, Samir, et al.
Izdano: (2024)

Natural products and their combinatory effects in breast cancer treatment
od: Siddique, Md. Ayman
Izdano: (2021)

Precision medicine in four deadliest Cancers of the world : present practices & future prospects
od: Islam, Ankita
Izdano: (2022)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
od: Hoque, Syeda Mehren
Izdano: (2024)

Microneedles in pain management of Cancer
od: Islam, Shafiqul
Izdano: (2022)

Breast cancer therapy through Liposomal drug delivery system
od: Ome, Nusrat Jahan
Izdano: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
od: Hossain, Safa Binte
Izdano: (2019)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
od: Muntaha, Habibatul
Izdano: (2023)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Karim, Samia Binte
Izdano: (2024)

Biosimilar in lymphoma treatment
od: Tanisha, Mehrin Haque
Izdano: (2021)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
od: Kamal, Tasnova
Izdano: (2019)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
od: Parvez, Safi
Izdano: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
od: Nashrah, Zannatul
Izdano: (2023)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
od: Rahman, Qazi Ashrafur
Izdano: (2018)